Stem stock: Stem receives NYSE notice. Stem stock remains listed during an 18-month cure plan

Published on 10/24/2026 at 04:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stem received an NYSE notice on October 23, 2026. The plan allows 45 days to file and 18 months to regain compliance for Stem stock.

Listing status and analyst view

Stem disclosed an NYSE compliance notice on October 23, 2026, tied to a USD 50.0 million threshold.
Second-quarter revenue was USD 33.65 million, down from USD 38.37 million a year earlier.
BMO Capital cut its target from USD 8.00 to USD 5.00 on October 21, 2026.

STEM, US85859N3008, Illustration mit AI erstellt.

Stem (ISIN US85859N3008) received a notice from the New York Stock Exchange on October 23, 2026, after the company disclosed that it did not meet a continued-listing standard. According to Financial Times, the standard requires average global market capitalization of at least USD 50.0 million over 30 trading days while stockholders equity also remains at least USD 50.0 million.

Notice sets an 18-month plan

Stem notified the NYSE on October 19, 2026, and received the exchange letter on October 20, 2026. The company plans to notify the NYSE within 10 business days that it intends to submit a business plan, then file that plan within 45 days of receiving the letter.

The plan must show how Stem expects to regain compliance within 18 months. The company said its common stock will continue to be listed and traded during the cure period, subject to NYSE review and acceptance of the plan.

Three dated stock events

On September 25, 2026, UBS upgraded Stem to Buy from Neutral and set a USD 7.00 target, according to MarketScreener. On October 14, 2026, Susquehanna cut its target from USD 7.50 to USD 4.50 while retaining a Neutral rating, as Markets Insider reported. The October 23, 2026, NYSE notice is the latest event.

What does the notice require?

The timetable gives Stem 45 days to present milestones and up to 18 months to restore compliance. That requirement adds execution pressure while the company works to expand its software-led clean-energy business.

Second-quarter figures set the backdrop

For the second quarter of 2026, revenue was USD 33.65 million, compared with USD 38.37 million in the second quarter of 2025, while GAAP net loss was USD 14.38 million. Those figures were reported by Markets Insider.

Next reporting date

Stem scheduled its third-quarter 2026 earnings call for November 5, 2026, covering the quarter ended September 30, 2026, according to the company release carried by Stem.

Stock remains near its yearly low

Stem had a market capitalization of USD 29.0 million and a 52-week range of USD 2.99 to USD 25.18 as of October 23, 2026. The low-end valuation helps explain why the NYSE threshold is central to the current stock story.

Stem was last at USD 3.01 on the NYSE on October 23, 2026, at 4:00 p.m. EDT. The further course of trading is shown by the continuously updated real-time quote of Stem stock.